Genmab Net Income from 2010 to 2026
| GMAB Stock | USD 26.36 -0.20 -0.75% |
Net Income | First Reported 2009-03-31 | Previous Quarter 401 M | Current Value 197 M | Quarterly Volatility 822.6 M |
Macro event markers
Analyzing Genmab AS's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Genmab AS's current valuation and future prospects.
Latest Genmab AS's Net Income Growth Pattern
Below is the plot of the Net Income of Genmab AS over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Genmab AS financial statement analysis. It represents the amount of money remaining after all of Genmab AS operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Genmab AS's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genmab AS's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 6.14 B | 10 Years Trend |
|
Net Income |
| Timeline |
Genmab Net Income Regression Statistics
| Arithmetic Mean | 2,558,721,427 | |
| Coefficient Of Variation | 107.30 | |
| Mean Deviation | 2,358,128,384 | |
| Median | 1,472,141,000 | |
| Standard Deviation | 2,745,427,659 | |
| Sample Variance | 7537373T | |
| Range | 8.4B | |
| R-Value | 0.94 | |
| Mean Square Error | 890399.5T | |
| R-Squared | 0.89 | |
| Slope | 512,687,020 | |
| Total Sum of Squares | 120597968.5T |
Genmab Net Income History
Other Related Fundumenentals
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Net Income component correlations
Methodology, Assumptions & Data Sources
This page provides reference data for Genmab AS's Net Income, tracking historical values and trends over time. Genmab AS has a current Net Income of 6.14 B. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Mean-reversion tendencies in this metric may inform forward estimates.
Unless otherwise specified, data for Genmab AS is compiled from periodic company reporting and market reference feeds and standardized for comparability. Where analyst coverage exists, consensus estimates are factored in. Updates may occur throughout the day. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.